文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

射血分数保留型与射血分数降低型心力衰竭的临床特征和虚弱状态。

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.

机构信息

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Kochi, 783-8505, Japan.

Department of Cardiology, Chikamori Hospital, Kochi, Japan.

出版信息

ESC Heart Fail. 2022 Jun;9(3):1853-1863. doi: 10.1002/ehf2.13885. Epub 2022 Mar 30.


DOI:10.1002/ehf2.13885
PMID:35355441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065850/
Abstract

AIMS: The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with reduced ejection fraction (HFrEF) in a super-aged region of Japan. METHODS AND RESULTS: Of the 1061 Japanese patients enrolled in the Kochi YOSACOI study, a multicentre registry, we divided 645 patients (median age of 81 years [interquartile range, 72-87 years]; women, 49.1%) into two groups, HFpEF patients (61.2%) and HFrEF patients (38.8%). Physical frailty was diagnosed on the basis of the Japanese version of Cardiovascular Health (J-CHS) Study criteria. Patients for whom left ventricular ejection fraction data were not available (n = 19), patients with heart failure with mildly reduced ejection fraction (n = 172), and patients who were not assessed by the J-CHS criteria (n = 225) were excluded. The median ages of the HFpEF and HFrEF patients were 84 and 76 years, respectively. The proportion of patients with HFpEF gradually increased with advance of age. The proportion of patients with three or more comorbidities was larger in HFpEF patients than in HFrEF patients (77.9% vs. 65.6%, P = 0.003). Handgrip strength was significantly lower in HFpEF patients than in HFrEF patients for both men (P < 0.001) and women (P = 0.041). Comfortable 5 m walking speed was significantly slower in HFpEF patients than in HFrEF patients (P < 0.001). The proportions of patients with physical frailty were 55.2% in HFpEF patients and 46.8% in HFrEF patients, and the proportion was significantly higher in HFpEF patients (P = 0.043). In multivariate analysis, physical frailty was associated with advanced age [odds ratio (OR), 1.030; 95% confidence interval (CI), 1.010-1.050; P = 0.023] and low albumin level (OR, 0.334; 95% CI, 0.192-0.582; P < 0.001) in HFpEF patients, and physical frailty was associated with women (OR, 2.150; 95% CI, 1.030-4.500; P = 0.042) and anaemia (OR, 2.840; 95% CI, 1.300-6.230; P = 0.003) in HFrEF patients. CONCLUSIONS: In a super-aged population of HF patients in Japan, HFpEF patients are more likely to be frail/have a high frailty status compared with HFrEF patients. The results suggested that physical frailty is associated with extracardiac factors in both HFpEF patients and HFrEF patients.

摘要

目的:本研究旨在阐明心力衰竭射血分数保留型(HFpEF)患者与射血分数降低型心力衰竭(HFrEF)患者的临床特征,包括虚弱状态,在日本的一个超老龄地区。

方法和结果:在 Kochi YOSACOI 研究的 1061 名日本患者中,我们将 645 名患者(中位年龄 81 岁[四分位距 72-87 岁];女性占 49.1%)分为两组,HFpEF 患者(61.2%)和 HFrEF 患者(38.8%)。根据日本心血管健康研究(J-CHS)标准诊断身体虚弱。排除了左心室射血分数数据不可用的患者(n=19)、射血分数轻度降低的心力衰竭患者(n=172)和未按 J-CHS 标准评估的患者(n=225)。HFpEF 和 HFrEF 患者的中位年龄分别为 84 岁和 76 岁。HFpEF 患者的比例随年龄的增长而逐渐增加。HFpEF 患者合并三种或三种以上合并症的比例高于 HFrEF 患者(77.9% vs. 65.6%,P=0.003)。男性(P<0.001)和女性(P=0.041)HFpEF 患者的握力均明显低于 HFrEF 患者。HFpEF 患者舒适的 5 米步行速度明显慢于 HFrEF 患者(P<0.001)。HFpEF 患者身体虚弱的比例为 55.2%,HFrEF 患者为 46.8%,HFpEF 患者明显更高(P=0.043)。多因素分析显示,HFpEF 患者中,身体虚弱与高龄(比值比[OR],1.030;95%置信区间[CI],1.010-1.050;P=0.023)和低白蛋白水平(OR,0.334;95%CI,0.192-0.582;P<0.001)相关,HFrEF 患者中,身体虚弱与女性(OR,2.150;95%CI,1.030-4.500;P=0.042)和贫血(OR,2.840;95%CI,1.300-6.230;P=0.003)相关。

结论:在日本超老龄心力衰竭患者人群中,HFpEF 患者比 HFrEF 患者更容易出现虚弱/高虚弱状态。结果表明,身体虚弱与 HFpEF 患者和 HFrEF 患者的心脏外因素有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/57c98d74b1d4/EHF2-9-1853-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/861fbc197136/EHF2-9-1853-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/36bce82658bf/EHF2-9-1853-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/5d3ed561ee53/EHF2-9-1853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/57c98d74b1d4/EHF2-9-1853-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/861fbc197136/EHF2-9-1853-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/36bce82658bf/EHF2-9-1853-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/5d3ed561ee53/EHF2-9-1853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0308/9065850/57c98d74b1d4/EHF2-9-1853-g002.jpg

相似文献

[1]
Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.

ESC Heart Fail. 2022-6

[2]
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction.

Eur J Prev Cardiol. 2021-8-9

[3]
Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction.

JACC Heart Fail. 2021-10

[4]
Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.

ESC Heart Fail. 2019-3-3

[5]
Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.

Eur J Anaesthesiol. 2022-8-1

[6]
[Clinical characteristics of heart failure with recovered ejection fraction].

Zhonghua Xin Xue Guan Bing Za Zhi. 2021-4-24

[7]
Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.

Am J Cardiol. 2017-6-1

[8]
Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction.

ESC Heart Fail. 2023-4

[9]
Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.

Clin Res Cardiol. 2019-4-12

[10]
Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction: a retrospective longitudinal study.

BMC Geriatr. 2021-2-1

引用本文的文献

[1]
Current state of heart failure management by home health-care professionals.

J Gen Fam Med. 2025-7-28

[2]
Muscle or Heart? Functional Impact of Sarcopenia and Heart Failure in Geriatric Inpatients.

J Clin Med. 2025-6-16

[3]
Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk Score.

J Am Heart Assoc. 2025-2-4

[4]
An Observational Study of Evidence-Based Therapies in Older Patients with Heart Failure with Reduced Ejection Fraction: Insights from a Dedicated Heart Failure Clinic.

J Clin Med. 2024-11-26

[5]
Real-World Evidence of Feasible Assessment and Intervention in Cardiovascular Physical Therapy for Older Patients With Heart Failure - Insight From the J-Proof HF of the Japanese Society of Cardiovascular Physical Therapy.

Circ Rep. 2024-9-21

[6]
Clinical characteristics and prognostic impact of atrial fibrillation among older patients with heart failure with preserved ejection fraction hospitalized for acute heart failure.

Intern Emerg Med. 2025-1

[7]
High-intensity care for GDMT titration.

Heart Fail Rev. 2024-9

[8]
The Impact of Acute Heart Failure on Frailty Degree and Outcomes in Elderly Patients with Severe Aortic Stenosis and Chronic Heart Failure with Preserved Ejection Fraction.

J Cardiovasc Dev Dis. 2024-5-14

[9]
Long-term prognostic value of the HFPEF score in patients undergoing transcatheter aortic valve implantation.

ESC Heart Fail. 2024-8

[10]
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.

J Cachexia Sarcopenia Muscle. 2024-2

本文引用的文献

[1]
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

N Engl J Med. 2021-10-14

[2]
Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.

ESC Heart Fail. 2021-8

[3]
Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.

N Engl J Med. 2021-7-15

[4]
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction.

Eur J Prev Cardiol. 2021-8-9

[5]
Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure.

Circ Heart Fail. 2020-10

[6]
Most elderly patients hospitalized for heart failure lack the abilities needed to perform the tasks required for self-care: impact on outcomes.

Eur J Heart Fail. 2019-8-1

[7]
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.

J Am Coll Cardiol. 2019-8-6

[8]
Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction.

Circ Heart Fail. 2018-11

[9]
The frailty syndrome and outcomes in the TOPCAT trial.

Eur J Heart Fail. 2018-9-18

[10]
Frailty Assessment in Heart Failure: an Overview of the Multi-domain Approach.

Curr Heart Fail Rep. 2018-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索